Mr Li, good morning. Good morning, everyone.
尊敬的李先生、各位来宾，早上好！
Thank you all for joining us to launch histotripsy1 in Singapore.
感谢各位今天与我们齐聚一堂，见证超声波组织碎化术系统在新加坡的发布会。
You have all just heard and seen how histotripsy works.
相信大家已经知道这项技术如何粉碎软组织。
In October 2023, less than 2 years ago, the USA FDA approved its first histotripsy system2 for treating liver cancer.
The major US medical centres3 now offer this breakthrough treatment.
不到两年之前，于2023年十月份，这项技术获得美国食品药品监督管理局的批准，成为世界上第一台治疗肝癌的超声波组织碎化设备，目前已被几家美国顶级医疗中心采用。
Last August, the Li Ka Shing Foundation donated 3 systems to Hong Kong4.
去年8月份，李嘉诚基金会向香港捐赠了3台该设备。
Soon after, Mr Li generously offered, through his Foundation, to gift a system to Singapore.
很快，李先生又通过其基金会，慷慨提议向新加坡捐赠1台设备。
Temasek Trust is very honoured to partner the Li Ka Shing Foundation to bring in not one, but two machines — one each for our 2 leading cancer centres5.
淡马锡信托基金会非常荣幸，能与李嘉诚基金会合作，扩大这项善举，联合为新加坡的两个主要的癌症中心各捐赠一台设备。
Our joint funding will also kickstart clinical trials to extend treatment to kidney and pancreatic cancers, in addition to cancers in the liver6.
我们的联合资金，也将用于启动肾癌和胰腺癌的临床试验，造福除了肝癌之外，更多的癌症患者。
TT Foundation Advisors, through its Donor Advised Fund, will work with other interested donors to expand clinical trials.
淡马锡信托基金会顾问也将通过其捐赠人建议基金，联合其它有意向的捐赠者，进一步扩大临床试验。
To Mr Li and the Li Ka Shing Foundation — a big thank you for your warm-hearted generosity to Singapore, and your trust in us.
在此，我要郑重感谢李先生和李嘉诚基金会，感谢您们的慷慨捐赠以及对我们的信任。
Mr Li, you inspire us with your patience in supporting medical research over decades, and you spur us with your impatience in bringing solutions quickly to serve the patients sooner than later.
李先生对医疗事业长久不懈的支持，和及时造益病人的迫切心情，让我们深受启发和触动。
To our doctors, scientists, and public health agencies — an enormous vote of thanks for your deep dedication to your patients, and your tireless drive to deliver better healthcare for all7.
在这里，我也要感谢我们的医生，科学家和公共卫生机构。 感谢您们为病人和医疗保健事业作出的杰出贡献。
I look forward to the success and authorisation of this non-invasive cutting-edge treatment in Singapore as the second hub in Asia — this will be immensely helpful for cancer patients and their families, from Singapore, Southeast Asia, and South Asia.
继香港之后，新加坡作为该技术的亚洲第二个中心，将造福东南亚、南亚及本地的癌症患者。让我们一起期待这项突破性的无创技术为亚洲的抗癌事业添砖加瓦！
[1] Coined at the University of Michigan in 2004; comes from Greek, where histo means soft tissue, and tripsy means to break down or to crush – cancer tissue can be broken up by popping micro-bubbles created by very short pulses of focused and intense ultrasound waves.
[2] HistoSonics Edison histotripsy system under the US FDA Breakthrough Device category.
[3] Includes Brigham and Women’s Hospital, Cleveland Clinic, Columbia University, Johns Hopkins Hospital, Mayo Clinic, MD Anderson Cancer Center, UChicago Medicine, University of Michigan, and several others in USA.
[4] HKU Li Ka Shing Faculty of Medicine, CUHK Faculty of Medicine, and Hong Kong Sanatorium & Hospital.
[5] National Cancer Centre Singapore and National University Cancer Institute, Singapore.
[6] The Li Ka Shing Foundation (LKSF) and Temasek Trust (TT) have committed S$12 million to bring innovative non-invasive ultrasound-based histotripsy tumour clinical trials to Singapore.
[7] One cancer specialist had already been reaching out to HistoSonics to explore bringing in this novel solution for our cancer patients, when this generous offer from the Li Ka Shing Foundation came.
